Acquired resistance to immunotherapy in MMR-D pancreatic cancer
ConclusionsThis is the first report describing acquired resistance to immunotherapy in MMR-D pancreatic cancer with accompanying genomic and immune profiling. This case of oligoprogression in the setting of immunotherapy demonstrates the feasibility of localized treatment followed by continuation of immunotherapy to sustain ongoing response.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Appendectomy | Cancer | Cancer & Oncology | Cancer of the Uterus | Clinical Trials | Hysterectomy | Immunotherapy | Ovarian Cancer | Ovaries | Pancreas | Pancreatic Cancer | Pathology